The mechanism(s) responsible for the insulin-like effects of vanadate
are still unclear, although several possible explanations have been ra
ised. However, the possibility that vanadate induces inhibition of ins
ulin degradation in the liver was not examined yet. Therefore, in the
present study we examined the effect of vanadate on the extraction of
insulin by the perfused rat liver using an open, non-recycling system.
Baseline insulin extraction (44+/-2% and 37+/-3%) was not affected by
the administration of 1 and 5 mu M vanadate (decreased to 42+/-2% and
36+/-1%, respectively, p = NS). Vanadate had no adverse effects on li
ver viability, and the bile flow remained stable during and after vana
date administration (0.87+/-0.08 mu l/min/g liver prior to Vs. 0.084+/
-0.11 mu l/min/g liver following vanadate administration). This study
shows that vanadate does not inhibit insulin extraction by the perfuse
d liver, and that doses of vanadate that effectively inhibit hepatic g
lucose production possess no adverse effects on liver viability.